Overview
- Published on August 21 in Nature, the multicenter study from the University of Cologne and Ospedale Pediatrico Bambino Gesù was led by Gianmaria Liccardi.
- Experiments show that activation of the immune sensor STING drives ZBP1-dependent necroptosis, defining a direct mechanistic basis for SAVI.
- Analyses of samples from affected children found clear evidence of aberrant activation of programmed cell death.
- In animal models, blocking necroptosis reduced symptoms, lowered disease severity, and significantly extended survival.
- The results support developing necroptosis inhibitors as a potential treatment for SAVI and other STING-linked inflammatory conditions, with clinical translation still to come.